The data obtained from the international literature, corresponding to that of the World Health Organization, report an incidence of lymphedema in the world of approximately 300 million cases (about one person in every 20). Almost half of lymphedema is of primary origin, characterized by a congenital Lymphangioadenodysplastic basis, that is due to a malformation and consequent malfunction of lymph nodes and / or lymphatic vessels. Another 70 million are of parasitic origin (the most frequent forms are represented by the infestation of Filaria Bancrofti), particularly present in tropical and subtropical areas (India, Brazil, South-Africa). Another 50 million are post-surgical and, especially, secondary to the treatment of breast cancer. The other 30 million are essentially caused by functional problems of overload of the lymphatic circulation (particularly, as a result of deep phlebothrombosis of the lower limb, liver failure, nephrotic syndrome, and arteriovenous fistulas).